These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 32239431)

  • 1. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
    Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
    BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging.
    Wang YL; Chen S; Xiao HF; Li Y; Wang Y; Liu G; Lou X; Ma L
    Radiother Oncol; 2018 Oct; 129(1):68-74. PubMed ID: 29398151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging.
    Choi YJ; Kim HS; Jahng GH; Kim SJ; Suh DC
    Acta Radiol; 2013 May; 54(4):448-54. PubMed ID: 23592805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
    Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
    Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas.
    Hashido T; Saito S; Ishida T
    Sci Rep; 2020 Apr; 10(1):6121. PubMed ID: 32273523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pseudoprogression in post-treatment glioblastoma using dynamic susceptibility contrast-derived oxygenation and microvascular transit time heterogeneity measures.
    Park JE; Kim HS; Kim N; Borra R; Mouridsen K; Hansen MB; Kim YH; Hong CK; Kim JH
    Eur Radiol; 2024 May; 34(5):3061-3073. PubMed ID: 37848773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-parameter arterial spin labeling versus dynamic magnetic-sensitive enhanced cerebral perfusion imaging for diagnosis of transient cerebral ischemic attack].
    Xu Y; Lv JH; Ma L; Chen WJ; Lou X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):768-74. PubMed ID: 27320876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging.
    Park H; Lee J; Park SH; Choi SH
    Korean J Radiol; 2019 Feb; 20(2):275-282. PubMed ID: 30672167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
    Morana G; Tortora D; Staglianò S; Nozza P; Mascelli S; Severino M; Piatelli G; Consales A; Lequin M; Garrè ML; Rossi A
    Neuroradiology; 2018 Apr; 60(4):437-446. PubMed ID: 29453753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme.
    Jovanovic M; Radenkovic S; Stosic-Opincal T; Lavrnic S; Gavrilovic S; Lazovic-Popovic B; Soldatovic I; Maksimovic R
    J BUON; 2017; 22(4):1061-1067. PubMed ID: 28952228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors.
    White CM; Pope WB; Zaw T; Qiao J; Naeini KM; Lai A; Nghiemphu PL; Wang JJ; Cloughesy TF; Ellingson BM
    J Neuroimaging; 2014; 24(1):23-30. PubMed ID: 22672084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of perfusion-weighted imaging combined with serum MMP-2 and -9 levels in tumor recurrence after postoperative concomitant chemoradiotherapy of glioblastoma.
    Liu W; Li Z
    J Clin Ultrasound; 2023 Mar; 51(3):563-570. PubMed ID: 36435971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion MR imaging of enhancing brain tumors: Comparison of arterial spin labeling technique with dynamic susceptibility contrast technique.
    Soni N; Dhanota DPS; Kumar S; Jaiswal AK; Srivastava AK
    Neurol India; 2017; 65(5):1046-1052. PubMed ID: 28879895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of normal-appearing white matter with perfusion and diffusion MRI in patients with treated glioblastoma.
    Şahin S; Ertekin E; Şahin T; Özsunar Y
    MAGMA; 2022 Feb; 35(1):153-162. PubMed ID: 34951690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.